CareFirst Pharmacy competitive response
CareFirst Pharmacy runs 62 stores across Maharashtra and Goa with revenue of ₹420 crore and an EBITDA margin of 6%. Private-label products contribute 8% of sales. Store footfall has fallen 12% over two years while e-pharmacies offer 20% discounts and home delivery; regulators are tightening prescription verification. CareFirst owns two warehouses, employs 1,800 people, and has strong pharmacist relationships in chronic-care categories. It plans to launch an app and a subscription refill service, but store managers fear losing walk-in customers and commissions. The CEO wants a competitive strategy that is not a simple price war, plus a way to implement it across stores without a mutiny.
1. Apply Porter’s five forces to CareFirst and identify which force most erodes its margins. Be specific to the case facts.
Read the worked answer
Rivalry is high: 62 stores compete with organised chains and e-pharmacies, and price transparency lets customers compare. CareFirst’s 6% EBITDA margin leaves little room for discounting.
Buyer power is high for chronic-care medicines and wellness products. Customers can switch easily, and e-pharmacies reduce search costs. However, acute prescriptions and pharmacist advice create some stickiness.
Supplier power is moderate. Pharmaceutical distributors have scale, but CareFirst’s two warehouses and 8% private-label share give it some bargaining leverage and a route to better margins.
Threat of new entrants is high from digital players with deep pockets, although prescription verification and licensing create regulatory barriers. The app plans show that CareFirst expects digital entry to continue.
Threat of substitutes is high: home delivery, hospital pharmacies, and e-pharmacy subscriptions substitute for store visits. This is the channel through which buyer power is exercised.
The force that most erodes margins is the combination of buyer power and rivalry transmitted through online substitutes. Customers compare prices, e-pharmacies discount 20%, and store footfall falls 12%. CareFirst cannot win a pure price war at 6% EBITDA; it must reduce the customer’s reason to compare on price alone. The next most important force is supplier power, because private label is only 8% and procurement savings are limited.
2. Recommend a competitive strategy and the value-chain changes needed to execute it. Include an implementation dashboard with at least four metrics.
Read the worked answer
Recommend a differentiation-focused strategy aimed at chronic-care patients and convenient refill, not a broad cost-leadership war. CareFirst should become the trusted adherence partner for chronic conditions: pharmacist counselling, refill reminders, home delivery, and a subscription that bundles medicines with monitoring. This uses the pharmacist relationships and store network that e-pharmacies cannot easily replicate.
Value-chain changes
- Procurement: raise private-label penetration from 8% to 15% over two years in selected chronic and wellness categories, using the two warehouses for pooled buying.
- Technology: launch the app as a refill and adherence tool, not a discount portal; integrate prescription verification and e-prescriptions.
- Operations: convert 8–10 stores into fulfilment hubs for same-day delivery; keep the remaining stores as counselling points. Do not close stores before pilot data.
- Sales and service: train pharmacists in chronic-care counselling; introduce a subscription with auto-refill and a helpline.
- Incentives: change store-manager commissions from counter sales to retained customers, refill rate, and private-label margin so managers do not sabotage the app.
Dashboard
- Chronic-care refill rate (target: +10 percentage points in 12 months).
- Private-label share of chronic-care sales (target: 15%).
- EBITDA per store and delivery cost per order (to ensure the model is not loss-making).
- App active refill customers and subscription churn.
- Customer NPS and prescription-verification compliance.
Implementation should start with a 10-store pilot, with monthly review and a clear rule that the app supports stores rather than bypasses them. If the pilot does not improve refill rate and contribution margin, stop and redesign; do not roll out a discount-led app across all 62 stores.